companydata.dkMACURE PHARMA ApS: Financial statements 2016
CVR: 35234748
MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 13,295,545 and a net result of DKK 9,095,436 compared with DKK 406,623 the year before. That is an increase of 1,854.2% compared with the year before. Equity amounted to DKK 5,457,810. The solvency ratio was 24.3%.
- Gross Profit
- 13,295,545 kr.
- Profit/Loss
- 9,095,436 kr.
- Equity
- 5,457,810 kr.
- Total Assets
- 22,454,060 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 13.3 mio. | 9.1 mio. | 5.5 mio. | - |
| 2015 | - | 680 t. | 407 t. | 823 t. | - |
| 2014 | - | 214 t. | 66 t. | 417 t. | - |
How creditworthy is MACURE PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
MACURE PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 680,373, and the net result was DKK 406,623.
As of January 1, 2016, Lars Mark Poulsen is registered as director of MACURE PHARMA ApS.
About MACURE PHARMA ApS
MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity amounted to DKK 18,033,649.